COMMONWEALTH EQUITY SERVICES, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$301
-13.3%
55,264
+6.8%
0.00%0.0%
Q2 2023$347
-21.3%
51,766
+3.6%
0.00%0.0%
Q1 2023$441
+5.0%
49,966
-9.2%
0.00%0.0%
Q4 2022$420
-99.9%
55,001
+2.4%
0.00%0.0%
Q3 2022$382,000
-9.9%
53,701
+2.3%
0.00%0.0%
Q2 2022$424,000
-43.2%
52,476
-2.6%
0.00%
-50.0%
Q1 2022$747,000
-43.5%
53,866
+14.2%
0.00%
-33.3%
Q4 2021$1,323,000
-37.3%
47,165
-24.0%
0.00%
-40.0%
Q3 2021$2,109,000
-20.4%
62,066
-4.2%
0.01%
-28.6%
Q2 2021$2,648,000
+56.0%
64,809
+53.7%
0.01%
+40.0%
Q1 2021$1,697,000
-32.3%
42,156
-0.5%
0.01%
-37.5%
Q4 2020$2,505,000
+19.1%
42,381
-2.1%
0.01%
+14.3%
Q3 2020$2,104,000
+3.2%
43,275
+2.6%
0.01%
-12.5%
Q2 2020$2,039,000
+74.3%
42,159
+0.1%
0.01%
+60.0%
Q1 2020$1,170,00042,1230.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders